Compare TOI & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOI | USNA |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.6M | 371.5M |
| IPO Year | N/A | 1996 |
| Metric | TOI | USNA |
|---|---|---|
| Price | $3.07 | $21.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $6.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.9M | 115.0K |
| Earning Date | 11-13-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $461,039,000.00 | ★ $912,670,000.00 |
| Revenue This Year | $28.51 | $10.42 |
| Revenue Next Year | $23.54 | $3.37 |
| P/E Ratio | ★ N/A | $24.72 |
| Revenue Growth | ★ 21.67 | 5.88 |
| 52 Week Low | $0.60 | $18.48 |
| 52 Week High | $4.88 | $38.32 |
| Indicator | TOI | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 63.95 |
| Support Level | $3.30 | $21.81 |
| Resistance Level | $3.68 | $22.59 |
| Average True Range (ATR) | 0.28 | 0.83 |
| MACD | -0.08 | 0.20 |
| Stochastic Oscillator | 2.04 | 76.68 |
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.